6260 related articles for article (PubMed ID: 33046317)
21. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
22. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
[TBL] [Abstract][Full Text] [Related]
23. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
24. [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].
Pfeifer M; Ewig S; Voshaar T; Randerath W; Bauer T; Geiseler J; Dellweg D; Westhoff M; Windisch W; Schönhofer B; Kluge S; Lepper PM
Pneumologie; 2020 Jun; 74(6):337-357. PubMed ID: 32323287
[TBL] [Abstract][Full Text] [Related]
25. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
Chand S; Kapoor S; Orsi D; Fazzari MJ; Tanner TG; Umeh GC; Islam M; Dicpinigaitis PV
J Intensive Care Med; 2020 Oct; 35(10):963-970. PubMed ID: 32812834
[TBL] [Abstract][Full Text] [Related]
26. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
27. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China.
Du RH; Liu LM; Yin W; Wang W; Guan LL; Yuan ML; Li YL; Hu Y; Li XY; Sun B; Peng P; Shi HZ
Ann Am Thorac Soc; 2020 Jul; 17(7):839-846. PubMed ID: 32255382
[No Abstract] [Full Text] [Related]
28. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
[TBL] [Abstract][Full Text] [Related]
29. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
Argenziano MG; Bruce SL; Slater CL; Tiao JR; Baldwin MR; Barr RG; Chang BP; Chau KH; Choi JJ; Gavin N; Goyal P; Mills AM; Patel AA; Romney MS; Safford MM; Schluger NW; Sengupta S; Sobieszczyk ME; Zucker JE; Asadourian PA; Bell FM; Boyd R; Cohen MF; Colquhoun MI; Colville LA; de Jonge JH; Dershowitz LB; Dey SA; Eiseman KA; Girvin ZP; Goni DT; Harb AA; Herzik N; Householder S; Karaaslan LE; Lee H; Lieberman E; Ling A; Lu R; Shou AY; Sisti AC; Snow ZE; Sperring CP; Xiong Y; Zhou HW; Natarajan K; Hripcsak G; Chen R
BMJ; 2020 May; 369():m1996. PubMed ID: 32471884
[TBL] [Abstract][Full Text] [Related]
30. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
31. The role of prone positioning in patients with SARS-CoV-2-related respiratory failure in non-intensive care unit.
Graziani M; Barbieri G; Maraziti G; Falcone M; Fiaccadori A; Corradi F; Ghiadoni L; Satula K; Noumi G; Becattini C
Ther Adv Respir Dis; 2023; 17():17534666231164536. PubMed ID: 37128996
[TBL] [Abstract][Full Text] [Related]
32. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
Guven BB; Erturk T; Kompe Ö; Ersoy A
Epidemiol Infect; 2021 Jun; 149():e137. PubMed ID: 34099076
[TBL] [Abstract][Full Text] [Related]
33. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
34. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
[TBL] [Abstract][Full Text] [Related]
36. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.
Kocayiğit H; Özmen Süner K; Tomak Y; Demir G; Kocayiğit İ; Yaylacı S; Aydemir Y; Köroğlu M; Karabay O; Öztürk MH; Erdem AF
Turk J Med Sci; 2021 Apr; 51(2):440-447. PubMed ID: 33185365
[TBL] [Abstract][Full Text] [Related]
38. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
39. Very severe COVID-19 in the critically ill in Tunisia.
Saida IB; Ennouri E; Nachi R; Meddeb K; Mahmoud J; Thabet N; Jerbi S; Boussarsar M
Pan Afr Med J; 2020; 35(Suppl 2):136. PubMed ID: 33193951
[TBL] [Abstract][Full Text] [Related]
40. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
